Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.

Cited by papers we hold 3

• Role of p53 in breast cancer progression: An insight into p53 targeted therapy · 2023
  No notice
• Gain-of-function mutant p53 in cancer progression and therapy · 2020
  No notice
• Targeting Oncogenic Mutant p53 for Cancer Therapy · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.